CFO resigns, new CFO and Independent Director appointed, Q3 results
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250 and 2.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q3 FY26 results showing revenue of Rs 35.58 crore (down from Rs 71.36 crore YoY) and PAT of Rs 5.15 crore. CFO Hitesh Makwana resigned citing pre-occupation; Naimish Bhatt (18 yrs exp) appointed new CFO. Independent Director Shailesh Thakkar resigned citing health issues; Kishan Raja (CA, 14 yrs) appointed. IPO funds fully on track with no deviation.
Multiple board changes alongside weak Q3 results. New appointments bring finance expertise. Watch transition closely.